Rankings
▼
Calendar
NVAX Q4 2018 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena
NVAX
Novavax, Inc.
$2B
Q4 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$6M
-41.2% YoY
Gross Profit
$6M
100.0% margin
Operating Income
-$47M
-759.1% margin
Net Income
-$49M
-805.2% margin
EPS (Diluted)
$-2.58
QoQ Revenue Growth
-20.8%
Cash Flow
Operating Cash Flow
-$45M
Free Cash Flow
-$46M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$208M
Total Liabilities
$376M
Stockholders' Equity
-$168M
Cash & Equivalents
$70M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$6M
$10M
-41.2%
Gross Profit
$6M
-$39M
+115.6%
Operating Income
-$47M
-$48M
+2.7%
Net Income
-$49M
-$51M
+3.0%
← FY 2018
All Quarters
Q1 2019 →